The ingredients commonly used in GLP-1 support have been researched primarily through oral intake, making oral supplements a more evidence-based choice (7,9,10,11,12)
Signs You May Have Toxic Overload Chronic toxic burden often presents as multi-system symptoms, including: Brain fog, memory issues, slowed thinking Migratory joint pain or unexplained muscle aches Chronic fatigue, burnout, post-exertional crashes Neuropathy, tingling, internal vibrations, twitching Sensitivity to light, sound, chemicals, or fragrances Digestive instability: bloating, constipation, diarrhea, nausea Sleep disturbances or unrefreshing sleep Anxiety, irritability, mood changes Hormonal instability or irregular cycles POTS-like symptoms, palpitations, dizziness Rashes, hives, eczema, psoriasis Weak immunity or frequent infections These symptom clusters are common in mold toxicity, Lyme disease, MCAS, chemical sensitivity, post-infectious syndromes, and complex chronic illness
Usage is restricted to certified laboratories
Telomere replication stress induced by POT1 inactivation accelerates tumorigenesis
Once they reach capacity (around 200mg at one time), the system hits its limit
The backstory: Earlier last month, President Donald Trump announced a deal with Eli Lilly and Novo Nordisk to expand coverage and reduce prices for GLP-1 drugs